Anthem Biosciences IPO Opens July 14, 2025
Anthem Biosciences Limited will launch its Initial Public Offering (IPO) on Monday, July 14, 2025. The IPO price band is set between ₹540 and ₹570 per equity share with a face value of ₹2 each. The anchor investor bidding will take place on Friday, July 11, 2025.
IPO Size and Offer Details
The IPO is an Offer for Sale worth up to ₹33,950 million by existing shareholders, including Ganesh Sambasivam, K Ravindra Chandrappa, Viridity Tone LLP, Portsmouth Technologies LLC, and others. Employees will get a reserved quota worth ₹82.50 million with a special discount of ₹50 per share.
Bidding Lot and Allocation Structure
Investors can bid for a minimum of 26 shares and in multiples thereafter. Up to 50% of the offer is reserved for Qualified Institutional Buyers (QIBs), 15% for Non-Institutional Investors, and at least 35% for Retail Individual Investors. Employees can also bid under the reserved portion.
Application Process
Bidders (except Anchor Investors) must apply through the ASBA process using their bank accounts or UPI. The shares are proposed to be listed on BSE and NSE. JM Financial, Citigroup, J.P. Morgan, and Nomura are the Book Running Lead Managers for this IPO.
Important Dates and RHP Link
The IPO bidding closes on Wednesday, July 16, 2025. For detailed information, investors can refer to the Red Herring Prospectus dated July 8, 2025 here.
